van Kessel J, Camilli A
J Bacteriol. 2024; 206(11):e0024824.
PMID: 39405459
PMC: 11580405.
DOI: 10.1128/jb.00248-24.
Holmgren J
J Infect Dis. 2021; 224(12 Suppl 2):S742-S748.
PMID: 34453544
PMC: 8687080.
DOI: 10.1093/infdis/jiab423.
Glenn G, Francis D, Danielsen E
Infect Immun. 2009; 77(12):5206-15.
PMID: 19737904
PMC: 2786446.
DOI: 10.1128/IAI.00712-09.
Bhattacharyya S, Shant J, Ganguly N, Majumdar S, Ghosh S
Curr Microbiol. 2007; 56(1):98-103.
PMID: 17990031
DOI: 10.1007/s00284-007-9048-x.
Holmgren J, Fredman P, Lindblad M, Svennerholm A, Svennerholm L
Infect Immun. 1982; 38(2):424-33.
PMID: 7141703
PMC: 347756.
DOI: 10.1128/iai.38.2.424-433.1982.
Nonimmunoglobulin fraction of human milk inhibits bacterial adhesion (hemagglutination) and enterotoxin binding of Escherichia coli and Vibrio cholerae.
Holmgren J, Svennerholm A, Ahren C
Infect Immun. 1981; 33(1):136-41.
PMID: 7021421
PMC: 350666.
DOI: 10.1128/iai.33.1.136-141.1981.
Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin.
Lindholm L, Holmgren J, Wikstrom M, Karlsson U, Andersson K, Lycke N
Infect Immun. 1983; 40(2):570-6.
PMID: 6840852
PMC: 264893.
DOI: 10.1128/iai.40.2.570-576.1983.
Production of cholera toxin-like toxin by Vibrio mimicus and non-O1 Vibrio cholerae: batch culture conditions for optimum yields and isolation of hypertoxigenic lincomycin-resistant mutants.
Spira W, Fedorka-Cray P
Infect Immun. 1983; 42(2):501-9.
PMID: 6642640
PMC: 264457.
DOI: 10.1128/iai.42.2.501-509.1983.
Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli.
Hirst T, Sanchez J, Kaper J, Hardy S, Holmgren J
Proc Natl Acad Sci U S A. 1984; 81(24):7752-6.
PMID: 6393126
PMC: 392230.
DOI: 10.1073/pnas.81.24.7752.
Membrane receptors for bacterial toxins.
Eidels L, Proia R, Hart D
Microbiol Rev. 1983; 47(4):596-620.
PMID: 6363900
PMC: 283710.
DOI: 10.1128/mr.47.4.596-620.1983.
Changes in intestinal fluid and mucosal immune responses to cholera toxin in Giardia muris infection and binding of cholera toxin to Giardia muris trophozoites.
Ljungstrom I, Holmgren J, Svennerholm A, Ferrante A
Infect Immun. 1985; 50(1):243-9.
PMID: 4044038
PMC: 262163.
DOI: 10.1128/iai.50.1.243-249.1985.
Low or undetectable levels of surface high affinity cholera toxin receptors on normal hemopoietic growth factor-dependent cells.
Lanotte M, Lacaze N
EMBO J. 1985; 4(12):3099-104.
PMID: 3912166
PMC: 554628.
DOI: 10.1002/j.1460-2075.1985.tb04051.x.
Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.
Black R, Levine M, Clements M, Young C, Svennerholm A, Holmgren J
Infect Immun. 1987; 55(5):1116-20.
PMID: 3552989
PMC: 260477.
DOI: 10.1128/iai.55.5.1116-1120.1987.
Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.
Jertborn M, Svennerholm A, Holmgren J
J Clin Microbiol. 1986; 24(2):203-9.
PMID: 3528211
PMC: 268875.
DOI: 10.1128/jcm.24.2.203-209.1986.
Two-dimensional crystals of cholera toxin B-subunit-receptor complexes: projected structure at 17-A resolution.
Ludwig D, Ribi H, Schoolnik G, Kornberg R
Proc Natl Acad Sci U S A. 1986; 83(22):8585-8.
PMID: 3464971
PMC: 386975.
DOI: 10.1073/pnas.83.22.8585.
Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
Lycke N, Holmgren J
Immunology. 1986; 59(2):301-8.
PMID: 3021614
PMC: 1453161.
Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.
Czerkinsky C, Russell M, Lycke N, Lindblad M, Holmgren J
Infect Immun. 1989; 57(4):1072-7.
PMID: 2925239
PMC: 313231.
DOI: 10.1128/iai.57.4.1072-1077.1989.
Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.
Migasena S, Desakorn V, Suntharasamai P, Pitisuttitham P, Prayurahong B, Supanaranond W
Infect Immun. 1989; 57(1):117-20.
PMID: 2909484
PMC: 313051.
DOI: 10.1128/iai.57.1.117-120.1989.
Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.
Migasena S, Pitisuttitham P, Suntharasamai P, Prayurahong B, Supanaranond W, Desakorn V
Infect Immun. 1989; 57(7):1942-5.
PMID: 2731977
PMC: 313824.
DOI: 10.1128/iai.57.7.1942-1945.1989.
Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.
Sanchez J, Holmgren J
Proc Natl Acad Sci U S A. 1989; 86(2):481-5.
PMID: 2492108
PMC: 286494.
DOI: 10.1073/pnas.86.2.481.